Schizophrenia Research
Volume 75, Issue 1 , Pages 1-3, 1 June 2005

No causative DLL4 mutations in periodic catatonia patients from 15q15 linked families

  • D.P. McKeane

      Affiliations

    • Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC 20010, United States
    • Department of Genetics, George Washington University, Washington, DC 20052, United States
  • ,
  • J. Meyer

      Affiliations

    • Department of Neuro-Behavioral Genetics, University of Trier, D-54290 Trier, Germany
  • ,
  • S.E. Dobrin

      Affiliations

    • Neurobehavioral Unit, Neurogenomics Program, The Translational Genomics Research Institute, Phoenix, AZ 85004, United States
  • ,
  • K.M. Melmed

      Affiliations

    • Neurobehavioral Unit, Neurogenomics Program, The Translational Genomics Research Institute, Phoenix, AZ 85004, United States
  • ,
  • S. Ekawardhani

      Affiliations

    • Department of Neuro-Behavioral Genetics, University of Trier, D-54290 Trier, Germany
  • ,
  • N.A. Tracy

      Affiliations

    • Research Center for Genetic Medicine, Children's National Medical Center, Washington, DC 20010, United States
  • ,
  • K.P. Lesch

      Affiliations

    • Clinical and Molecular Psychobiology, Department of Psychiatry and Psychotherapy, University of Wuerzburg, D-97080 Wuerzburg, Germany
  • ,
  • D.A. Stephan

      Affiliations

    • Neurobehavioral Unit, Neurogenomics Program, The Translational Genomics Research Institute, Phoenix, AZ 85004, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 602 3438727; fax: +1 602 3438844.

Received 20 February 2004; received in revised form 21 July 2004; accepted 26 July 2004.

Abstract 

Two well-supported theories of schizophrenia pathogenesis are the neurotransmitter theory and the neurodevelopmental theory, suggesting, respectively, that dysregulation of neurotransmitter signaling and abnormal brain development are causative in this disease. The strongest evidence of neurotransmitter involvement are suggestions of abnormal dopamine signaling in the prefrontal cortex and one of the strongest indications of developmental abnormalities contributing to this disease is an inverse layering of the prefrontal cortex. These two theories of schizophrenia pathogenesis can be united by their involvement of the prefrontal cortex, where structural abnormalities could lead to neurochemical abnormalities. Accordingly, any gene expressed in the prefrontal cortex of developing brains is a functional candidate for schizophrenia. We have previously reported strong linkage to 15q15 (LOD=3. 57; P=2.6×105) in a collection of German multiplex families segregating the periodic catatonia subtype of schizophrenia in a nearly Mendelian fashion. A gene within our 15q15 linkage region, DLL4, is expressed in developing forebrain and produces a NOTCH4 ligand. Variants of NOTCH4 are associated with schizophrenia, thus DLL4 is both a functional as well as a positional candidate for schizophrenia. We screened this gene for mutations in three affected individuals and two unrelated controls and found two previously unreported SNPs, one non-synonymous polymorphism that changed an arganine to a histadine in Exon 7 and one synonymous polymorphism in exons. The non-synonymous SNP is a rare variant in that it was not found in 100 control chromosomes; however, it did not cosegregate with the disease in the extended family so it is not causative in this pedigree. It is unlikely that mutations in DLL4 are causative in this collection of families with linkage to 15q15.

Keywords: Schizophrenia, Single nucleotide polymorphism, Single-stranded conformational polymorphism (SSCP), Prefrontal cortex, NOTCH4, Dopamine, DLL4

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(04)00238-5

doi:10.1016/j.schres.2004.07.017

Schizophrenia Research
Volume 75, Issue 1 , Pages 1-3, 1 June 2005